AJ
Abhinav Jain
About Abhinav Jain
Data last updated:
Abhinav Jain is a Director at Rx Plus Pharmaceuticals Private Limited (since 2023) and Designated Partner at Stelfliers Global Llp (since 2022). The companies operate in Home Appliances and Construction. The largest current company by reported revenue is Rx Plus Pharmaceuticals Private Limited at ₹30.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rx Plus Pharmaceuticals Private Limited U51397DL2023PTC409712 | Director | 10 Jan 2023 | 2023 | ₹30.6 Lakh (FY 2025) | Active |
| Stelfliers Global Llp ABA-3704 | Designated Partner | 25 Jan 2022 | 2022 | Active |
Board colleagues of Abhinav Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Parveen | 08618778 | Rx Plus Pharmaceuticals Private Limited , Stelfliers Global Llp | Director |
| Sudha Jain | 09479830 | Rx Plus Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhinav Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhinav Jain
Abhinav Jain currently holds 2 directorships: Rx Plus Pharmaceuticals Private Limited (Director, since 10 Jan 2023, revenue ₹30.6 Lakh (FY 2025)); Stelfliers Global Llp (Designated Partner, since 25 Jan 2022).
Abhinav Jain was first appointed on 25 Jan 2022 as Designated Partner at Stelfliers Global Llp. The most recent appointment on record is 10 Jan 2023 at Rx Plus Pharmaceuticals Private Limited.
The current boards of Abhinav Jain's companies include Parveen (Rx Plus Pharmaceuticals Private Limited), Sudha Jain (Rx Plus Pharmaceuticals Private Limited).